247 related articles for article (PubMed ID: 14570772)
21. A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine.
Hashizume T; Mise M; Matsumoto S; Terauchi Y; Fujii T; Imaoka S; Funae Y; Kamataki T; Miyazaki H
Drug Metab Dispos; 2001 Jun; 29(6):798-805. PubMed ID: 11353747
[TBL] [Abstract][Full Text] [Related]
22. Regiochemical differences in cytochrome P450 isozymes responsible for the oxidation of methylenedioxyphenyl groups by rabbit liver.
Kumagai Y; Lin LY; Philpot RM; Yamada H; Oguri K; Yoshimura H; Cho AK
Mol Pharmacol; 1992 Oct; 42(4):695-702. PubMed ID: 1435745
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
Raner GM; Vaz AD; Coon MJ
Mol Pharmacol; 1996 Mar; 49(3):515-22. PubMed ID: 8643091
[TBL] [Abstract][Full Text] [Related]
24. Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate.
Nakajima M; Yoshida R; Shimada N; Yamazaki H; Yokoi T
Drug Metab Dispos; 2001 Aug; 29(8):1110-3. PubMed ID: 11454729
[TBL] [Abstract][Full Text] [Related]
25. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
Danek PJ; Wójcikowski J; Daniel WA
Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
[TBL] [Abstract][Full Text] [Related]
26. Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.
Lu P; Schrag ML; Slaughter DE; Raab CE; Shou M; Rodrigues AD
Drug Metab Dispos; 2003 Nov; 31(11):1352-60. PubMed ID: 14570767
[TBL] [Abstract][Full Text] [Related]
27. Effect of an extract of the root of Scutellaria baicalensis and its flavonoids on aflatoxin B1 oxidizing cytochrome P450 enzymes.
Kim BR; Kim DH; Park R; Kwon KB; Ryu DG; Kim YC; Kim NY; Jeong S; Kang BK; Kim KS
Planta Med; 2001 Jul; 67(5):396-9. PubMed ID: 11488450
[TBL] [Abstract][Full Text] [Related]
28. In vitro inhibition of Huanglian [Rhizoma coptidis (L.)] and its six active alkaloids on six cytochrome P450 isoforms in human liver microsomes.
Han YL; Yu HL; Li D; Meng XL; Zhou ZY; Yu Q; Zhang XY; Wang FJ; Guo C
Phytother Res; 2011 Nov; 25(11):1660-5. PubMed ID: 21425377
[TBL] [Abstract][Full Text] [Related]
29. Identification of cytochrome P450 and arylamine N-acetyltransferase isoforms involved in sulfadiazine metabolism.
Winter HR; Unadkat JD
Drug Metab Dispos; 2005 Jul; 33(7):969-76. PubMed ID: 15843491
[TBL] [Abstract][Full Text] [Related]
30. Analysis of goldenseal, Hydrastis canadensis L., and related alkaloids in urine using HPLC with UV detection.
Dawes ML; Brettell T
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):114-8. PubMed ID: 22177787
[TBL] [Abstract][Full Text] [Related]
31. Mechanism-based inhibition of human liver microsomal cytochrome P450 2D6 (CYP2D6) by alkamides of Piper nigrum.
Subehan ; Usia T; Kadota S; Tezuka Y
Planta Med; 2006 May; 72(6):527-32. PubMed ID: 16808005
[TBL] [Abstract][Full Text] [Related]
32. Interactions between cytochromes P450, glutathione S-transferases and Ghanaian medicinal plants.
Appiah-Opong R; Commandeur JN; Axson C; Vermeulen NP
Food Chem Toxicol; 2008 Dec; 46(12):3598-603. PubMed ID: 18822337
[TBL] [Abstract][Full Text] [Related]
33. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
Nassar AE; King I; Paris BL; Haupt L; Ndikum-Moffor F; Campbell R; Usuki E; Skibbe J; Brobst D; Ogilvie BW; Parkinson A
Drug Metab Dispos; 2009 Sep; 37(9):1922-30. PubMed ID: 19520774
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
Baranczewski P; Edlund PO; Postlind H
J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862
[TBL] [Abstract][Full Text] [Related]
35. Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.
Zhang JG; Dehal SS; Ho T; Johnson J; Chandler C; Blanchard AP; Clark RJ; Crespi CL; Stresser DM; Wong J
Drug Metab Dispos; 2006 May; 34(5):734-7. PubMed ID: 16501008
[TBL] [Abstract][Full Text] [Related]
36. Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein.
Deeni YY; Paine MJ; Ayrton AD; Clarke SE; Chenery R; Wolf CR
Arch Biochem Biophys; 2001 Dec; 396(1):16-24. PubMed ID: 11716457
[TBL] [Abstract][Full Text] [Related]
37. Metabolite-P450 complex formation by methylenedioxyphenyl HIV protease inhibitors in rat and human liver microsomes.
Chiba M; Nishime JA; Chen IW; Vastag KJ; Sahly YS; Kim BM; Dorsey BD; Vacca JP; Lin JH
Biochem Pharmacol; 1998 Jul; 56(2):223-30. PubMed ID: 9698076
[TBL] [Abstract][Full Text] [Related]
38. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
Akutsu T; Kobayashi K; Sakurada K; Ikegaya H; Furihata T; Chiba K
Drug Metab Dispos; 2007 Jan; 35(1):72-8. PubMed ID: 17020955
[TBL] [Abstract][Full Text] [Related]
39. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs.
Li J; Liu Y; Zhang JW; Wei H; Yang L
Comp Med; 2006 Aug; 56(4):286-90. PubMed ID: 16941956
[TBL] [Abstract][Full Text] [Related]
40. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
